SEC Form 4 · accession 0000899243-18-008700
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jake Bauer
Officer — See Remarks
Period of report
Mar 26, 2018
Accepted (ET)
Mar 28, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 26, 2018 | M | 164 | $9.08 | A | 61,941 | D | |
| Common Stock | Mar 26, 2018 | S | 164 | $50.95 | D | 61,777 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.08 | Mar 26, 2018 | M | 164 | D | — | Feb 1, 2026 | Common Stock | 164 | 28,748 | D |
Explanation of responses
- F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020.
Remarks
Senior Vice President, Finance and Corporate Development